Search

everythinglearnresearchcommunity

for

Search:↓

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Yikgeebohyul-tang promotes hair growth and could help treat hair loss.

Apremilast did not work for treating severe alopecia areata.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

UV radiation can help sterilize wounds and promote healing but requires careful use to avoid damaging cells.

Substance P may worsen acne by increasing inflammation, but corticosteroids might help by reducing this effect.

The skin is a complex barrier that protects the body, regulates temperature, and helps with immune responses.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Pimecrolimus cream is not effective for treating alopecia areata.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Ruxolitinib treatment may cause eyelash growth.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Apremilast shows promise for several skin conditions but needs more research.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Finasteride helps female-pattern hair loss.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Platelet-rich plasma can potentially promote hair growth by stimulating cell growth and increasing certain proteins.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.